Lesson · 40 min · Free
Experiment Tracking & Reproducibility
Experiment Tracking & Reproducibility body { font-family: sans-serif; line-height: 1.6; margin: 20px; } h1, h2 { color: #2c3e50; } pre { background-color: #ecf0f1; padding: 15px; border-radius: 5px; overflow-x: auto; } c
Experiment Tracking & Reproducibility
In the rapidly evolving field of AI in drug discovery, the ability to track, manage, and reproduce experimental results is paramount. Unlike traditional wet-lab experiments where protocols are often meticulously documented in physical lab notebooks, AI experiments involve complex software environments, large datasets, and numerous configurable parameters. Without proper tracking, it becomes incredibly difficult to understand why a particular model performed well (or poorly), to compare different approaches systematically, or to rebuild a model from scratch months later. Reproducibility ensures that scientific findings can be independently verified, building trust and accelerating progress in drug discovery. Experiment tracking involves systematically recording all relevant information about each AI model training run. This includes hyperparameters, dataset versions, code versions, environmental configurations, and performance metrics. By logging this data, researchers can gain insights into how different choices impact model performance, facilitating iterative improvement and informed decision-making. Reproducibility, on the other hand, is the ability to achieve the same results (or very similar results within expected variability) when an experiment is re-run with the same inputs and methodology.
Why Experiment Tracking and Reproducibility are Critical in Drug Discovery
For drug discovery, the stakes are exceptionally high. AI models might be used to predict molecular properties, identify potential drug candidates, or optimize synthesis pathways. A lack of reproducibility could lead to significant financial losses, wasted resources, and, more critically, could compromise patient safety if flawed models are used to inform critical decisions. Imagine a scenario where a promising drug candidate is identified by an AI model, but the results cannot be reproduced due to undocumented changes in the model's training process or data preprocessing. This could lead to delays in drug development, or worse, the pursuit of a non-viable compound. Modern machine learning operations (MLOps) platforms and dedicated experiment tracking tools have emerged to address these challenges. These tools provide structured ways to log experiment metadata, version control code and data, and visualize performance trends. They help bridge the gap between initial research and scalable deployment, ensuring that AI models used in drug discovery are robust, reliable, and auditable. One common approach to tracking experiments is to use a dedicated library or platform. Tools like MLflow, Weights & Biases, or Comet ML allow you to log parameters, metrics, artifacts (like trained model files or plots), and even the source code itself. Below is a simplified example using a hypothetical logging function, demonstrating how one might track key parameters for a drug-target interaction prediction model. import pandas as pd from sklearn.model_selection import train_test_split from sklearn.ensemble import RandomForestClassifier from sklearn.metrics import roc_auc_score # Assume a hypothetical experiment tracking library import experiment_tracker as et # --- Experiment Configuration --- MODEL_NAME = "RandomForest_DrugTarget" DATASET_VERSION = "v1.2_curated_ligand_protein_pairs" RANDOM_STATE = 42 N_ESTIMATORS = 100 MAX_DEPTH = 10 FEATURES_USED = ["mol_fingerprint", "protein_sequence_embedding"] # --- Load and Prepare Data (placeholder) --- # In a real scenario, this would load actual drug-target interaction data data = pd.DataFrame({ 'mol_fingerprint': [[0.1, 0.2, ...], ...], 'protein_sequence_embedding': [[0.5, 0.6, ...], ...], 'interaction_label': [0, 1, 0, ...] }) X = data[FEATURES_USED] y = data['interaction_label'] X_train, X_test, y_train, y_test = train_test_split(X, y, test_size=0.2, random_state=RANDOM_STATE) # --- Start Experiment Tracking --- et.start_run(run_name=f"{MODEL_NAME}_run_1") et.log_param("model_type", "RandomForestClassifier") et.log_param("dataset_version", DATASET_VERSION) et.log_param("random_state", RANDOM_STATE) et.log_param("n_estimators", N_ESTIMATORS) et.log_param("max_depth", MAX_DEPTH) et.log_param("features_used", str(FEATURES_USED)) # Log as string for simplicity # --- Train Model --- model = RandomForestClassifier(n_estimators=N_ESTIMATORS, max_depth=MAX_DEPTH, random_state=RANDOM_STATE) # Convert list of lists to numpy array for scikit-learn X_train_np = pd.DataFrame(X_train.tolist()).values X_test_np = pd.DataFrame(X_test.tolist()).values model.fit(X_train_np, y_train) # --- Evaluate Model --- y_pred_proba = model.predict_proba(X_test_np)[:, 1] auc_score = roc_auc_score(y_test, y_pred_proba) et.log_metric("roc_auc_score", auc_score) # --- End Experiment Tracking --- et.end_run() print(f"Experiment {MODEL_NAME}_run_1 completed. AUC: {auc_score:.4f}") Beyond logging parameters and metrics, version control for data and code is fundamental for reproducibility. Data versioning ensures that the exact dataset used for a specific experiment can be retrieved at any time. Similarly, code versioning (e.g., using Git) allows you to revert to the precise code state that produced a particular result. Tools like DVC (Data Version Control) can integrate with Git to manage large datasets and models, providing a comprehensive versioning solution. Consider the following example demonstrating how DVC might be used to track a dataset. This command would be run in your terminal, not as part of a Python script. # Initialize DVC in your project directory (if not already done) # dvc init # Add a data file or directory to DVC tracking # This will create a .dvc file that tracks the data and add it to Git dvc add data/processed_drug_screening_results.csv # Commit the .dvc file to Git, effectively versioning your data git add data/processed_drug_screening_results.csv.dvc git commit -m "Add processed drug screening results v1.0" # If you later modify the data, you would run: # dvc add data/processed_drug_screening_results.csv # git commit -m "Update processed drug screening results to v1.1" # To retrieve a specific version of the data (e.g., from a previous Git commit) # git checkout # dvc checkout By combining dedicated experiment tracking platforms with robust data and code versioning, AI researchers in drug discovery can establish a strong foundation for reliable and verifiable scientific progress. This systematic approach not only enhances individual productivity but also fosters collaborative research and accelerates the translation of AI models from research to clinical impact. Experiment tracking is the systematic recording of all relevant information (hyperparameters, metrics, code, data versions) for each AI model training run. Reproducibility is the ability to achieve the same or very similar results when an experiment is re-run with identical inputs and methodology. These practices are critical in drug discovery to ensure reliability, prevent waste, and maintain patient safety. Tools like MLflow, Weights & Biases, Comet ML, and DVC facilitate robust experiment tracking and data/code versioning. A lack of reproducibility can lead to significant delays, financial losses, and compromise the integrity of scientific findings in drug development.
Practice Exercise: Designing a Tracking Strategy
Imagine you are developing an AI model to predict the binding affinity of small molecules to a specific protein target. You are experimenting with different molecular featurization methods (e.g., ECFP4, Morgan fingerprints, RDKit descriptors), various machine learning algorithms (e.g., Random Forest, Gradient Boosting, GNNs), and hyperparameter settings for each. Describe, in detail, what information you would track for each experiment to ensure both reproducibility and efficient comparison of your models. Consider aspects like data, code, environment, and specific model parameters. How would you structure this information so that another researcher could easily recreate your best-performing model?
Watch the full lesson — free
This topic is part of AI in Drug Discovery, a complete AI-narrated video course. Press play once and watch the entire lecture like a movie.
Start the course free →